Sarah Sammons: Peter Attia breaking down ctDNA for CRC screening
Sarah Sammons shared a post on X:
”I have become a fan of Peter Attia since reading his book ‘Outlive’ which discusses the science of longevity and preventative medicine.
Here, he breaks down ctDNA for CRC screening.
A new blood test doesn’t change the game for CRC screening.”
Source: Sarah Sammons/X
Sarah Sammons is a medical oncologist at Dana-Farber’s Breast Oncology Center specializing in treating patients with all stages of breast cancer. She is particularly focusing on improving outcomes for those with metastatic breast cancer. Through leading numerous clinical trials, she has developed new treatment options for breast cancer patients. Additionally, Dr. Sammons is skilled in treating brain metastases.
Peter Attia is a physician and co-founder of Ten Squared and Early. He hosts “The Peter Attia Drive” podcast and specializes in the applied science of longevity. His practice focuses on enhancing lifespan and healthspan through nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023